0 Items
Select Page

Usutu Virus

The first human case of Usutu viral infection was identified in the Central African Republic in 1981. The first human cases to be documented in Europe, were in Italy in 2009. These European cases were also the first to exhibit neurological manifestation of the disease, as the only two previous cases in Africa exhibited fever, rash, and jaundice. This relatively unknown and emerging zoonotic virus highlights the importance of vector-borne disease surveillance for human health.

At The Native Antigen Company, we have developed recombinant Usutu NS1 proteins to support research into the disease and development of specific immunoassays.

Usutu Virus Background

Usutu virus (USUV) is an enveloped, positive-sense, single-stranded RNA virus that belongs to the genus Flavivirus. USUV is a member of the Japanese encephalitis sero-complex of the family Flaviridae and is related to West Nile virus. The Usutu virus is maintained in a cycle between birds, which are regarded as the primary reservoir and amplification host, in addition to ornithophilic mosquitoes. USUV has also been reported to infect humans, horses and bats, which act as incidental hosts (Ashraf, U. et al). Usutu virus is recognised as an emerging pathogen and has recently been isolated from the mosquito species, C. pipiens, raising concerns that the mosquito species may act as a bridge vector, enabling transmission of USUV to mammals (Pauli, G et al).

USUV was first identified in South Africa in 1959, but later emerged in Austria in 2001, spreading throughout Europe and the Asian continent to infect a wide variety of bird species. In Europe, circulating USUV causes severe neurological symptoms in birds and is responsible for significant numbers of deaths in bird populations, including blackbirds and great grey owls. Although USUV is recognised as an emerging pathogen, little is known about USUV pathogenesis in humans. Cases of human USUV infection are uncommon but significant neurological disorders, such as encephalitis and meningoencephalitis have been reported in immunocompromised and immunocompetent patients infected with USUV (Salinas, S. et al).

References

  1. Ashraf, U et al (2015). Usutu Virus: An Emerging Flavivirus in Europe. Viruses. 7: 219–238.
  2. Pauli, G et al (2014). Usutu Virus. Transfus. Med. Hemother. 41: 73–82.
  3. Salinas, S et al (2017). Deleterious effect of Usutu virus on human neural cells. PLoS Negl. Trop Dis. 11: e0005913.

Usutu Antigens

The Native Antigen Company prepare recombinant Usutu virus NS1 protein in a proprietary mammalian cell expression system, to generate highly pure NS1 protein in its glycosylated and predominantly hexameric form.

Questions?

Check out our FAQ section for answers to the most frequently asked questions about our website and company.

Diagnosing HIV in resource-limited settings

In this blog, we discuss the need for improved point-of-care (PoC) diagnostics for HIV and present the virus's cellular mechanism to illustrate our new range of HIV antigens and antibodies. HIV in the developed world On June 5th 1981 in Los Angeles, California, 5...

Our Product Pipeline

If you’ve been following us on social media recently, you might have noticed that we’ve been releasing a lot of new antigens and antibodies. In this blog, we explain how we use the WHO R&D Blueprint to guide our product development and present some highlights from...

From Outbreak to Epidemic: A Short History of The Ebola Virus

In the first of a two-part series, we discuss the history of the Ebola virus up to the ongoing outbreak in the Democratic Republic of Congo, and why this disease has been so challenging to fight. The 2014/15 epidemic In the summer of 2014, the world watched as the...

ELISA Formats for Infectious Disease Diagnostics

The field of diagnostics is rapidly developing, yet ELISA and PCR methods remain the most commonly used techniques in the diagnosis of bacterial and viral infections. In this blog, we discuss the advantages of using serological methods over molecular, PCR-based...

The world’s most extensive range of NS1-specific antibodies for flavivirus research

The Native Antigen Company first gained prominence in 2016, when it developed highly pure Zika virus NS1 protein during the 2015/2016 epidemic. Since then, the company has developed an extensive range of highly specific antigens, antibodies and immunoassays for...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

14 + 3 =

Live Customer Feedback

Join our mailing list

* indicates required